Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
5 Ways to Beat the Fed (and Crush Inflation)
Twitter
Tags: apple
Stocks: AAPL, FB

Big Pharma's Biggest Enemy Is... Apple?

By Casey Wilson, Associate Editor, Money Morning • April 13, 2017

View Comments

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

appleBig Pharma has a new contender to worry about...

Tech giant Apple Inc. (Nasdaq: AAPL) has hired a small team of biomedical science engineers to develop revolutionary blood sugar sensors, according to an April 13 report by CNBC.

In fact, the team has been quietly developing the devices since before the death of former Apple CEO Steve Jobs.

If successful, the advance could help millions of diabetes patients and turn the Apple Watch - which the sensors are rumored to pair with - from a "nice to have" into a "must have."

And now, at a time when Big Pharma has been put under the spotlight for exuberant drug costs, unfair pricing practices, and outrageous CEO behavior, Apple may be in the perfect position to snap up market share...

The "Glucose Team" Is Taking Over

Apple's efforts to jump into the health and science industry have been going on for at least five years. The initiative was set forth by then CEO Steve Jobs, who "envisioned wearable devices, like smartwatches, being used to monitor important vitals, such as oxygen levels, heart rate, and blood glucose," wrote CNBC.

Under Jobs' watch, the company snatched up top talent from about a dozen biomedical research firms and placed them on "teams" - such as the "glucose team" or the Apple Watch team - with the intention of merging the two teams' ideas.

Accurately detecting glucose levels is no easy feat. In fact, developing the technology is such a challenge that one of the top experts in the industry, John L. Smith, a recognized expert and pioneer in the field of noninvasive glucose monitoring, described it as "the most difficult challenge I have ever encountered" to CNBC.

Sign up for SMS so you never miss special events, exclusive offers, and weekly bonus trades.
Must Read: Top 10 2017 IPOs to Watch

To succeed would cost a company "several hundred millions or even a billion dollars," DexCom Executive Chairman Terrance Gregg told Reuters in 2014, when the speculation started swirling.

But the challenge has not stopped Apple from stepping up to the plate.

And if the sensors are included in a future edition of the Apple Watch - as suspected - Apple may have a significant advantage over traditional pharma companies.

You see, Big Pharma's glucose monitoring systems cost anywhere from $400 to $800 for standard models, while the latest Apple watch retails for $369.

Even more enticing, the Apple Watch includes other consumer health-related features, like a built-in heart rate sensor, waterproof capability, and deep-breathing exercises.

What All This Means for Investors

The line between pharmaceuticals and technology is blurring, and now is the best time to invest in "bioelectronics" - an emerging industry worth over $25 billion.

In fact, Global Market Insights reported this industry is growing at more than 10% a year, over 10 times faster than the entire U.S. economy.

"The greatest investments of this time are all related to technology," said Money Morning Capital Wave Strategist Shah Gilani. "Tech is taking over. Big data is consuming the market."

In fact, Gilani predicts that software and tech companies like Apple and Facebook Inc. (Nasdaq: FB) will completely take over various industries in the future - especially healthcare.

"I think this year is going to be great for Apple," said Gilani on "Varney & Co." April 13. "There are going to be some breakthroughs there."

Additionally, "Facebook has all of this great data to work with," said Gilani. "If they're smart, they will merge with the healthcare industry in the near future. Think about it - people trust Facebook. People give all of their information to Facebook. Why not use all that Facebook data for your well-being?"

And Facebook may already be creeping into the sector...

According to CNBC, Apple's "glucose team" was previously led by Michael D. Hillman, who left Apple in late 2015.

Curiously enough, Hillman joined Facebook's Oculus as head of hardware last month.

Editor's Note: One of the fastest-growing tech investment segments is... cannabis? Yes, you read that right. A high-tech approach to cultivating this ancient plant - that's already legal to use in more than half of 50 states - is generating a multibillion-dollar investment opportunity for early investors. Click here to find out more, including how you can get your copy of Michael Robinson's Roadmap to Marijuana Millions. Packed with more than 30 great companies to buy, it's fast becoming "the weed investor's bible." Check it out...

Follow Money Morning on Twitter @moneymorning, Facebook, and LinkedIn.

Join the conversation. Click here to jump to comments…

Login
guest
guest
2 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Peter OAKLEY
Peter OAKLEY
6 years ago

Pls keep me informed about Apple, and motoring technology news

0
Reply
Casey Wilson
Casey Wilson
6 years ago
Reply to  Peter OAKLEY

Hi Peter! You can always sign up for our Profit Alerts feature, located on the right-hand side of the homepage (www.MoneyMorning.com) to stay up-to-date with the current news.

Make sure to select "Apple Updates" and "Tech Watch" as well as any other topics you might be interested in!

Thanks for your comment :)

Best,

Casey Wilson

0
Reply


Latest News

June 1, 2023 • By Nick Black

Apple-Broadcom Deal Sets the Stage for U.S. Tech Resurgence and Investment Opportunities

June 1, 2023 • By Garrett Baldwin

This Investor Taught Warren Buffett Everything He Knows - Let's Put Him to Work for Us

June 1, 2023 • By Shah Gilani

earnings
Here's What to Do When the Stock Market's A.I. Hype Fades Out
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Flashpoint Trader Darknet Hyper Momentum Trader Alpha Accelerators Weekly Profit Cycles Brutus Alerts Resource Traders Alliance

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz